Article
Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 May 2008
Quick Sylvia K, Shields Peter G, Nie Jing, Platek Mary E, McCann Susan E, Hutson Alan D, Trevisan Maurizio, Vito Dominica, Modali Ramakrishna, Lehman Teresa A, Seddon Mike, Edge Stephen B, Marian Catalin, Muti Paola, Freudenheim Jo L
Abstract excerpt
Catalase, a ubiquitous heme enzyme, catalyzes conversion of hydrogen peroxide to water and molecular oxygen, protecting cells from oxidative stress. A C/T polymorphism in the promoter region of the CAT gene (rs1001179) affects transcriptional activity and RBC catalase levels. Oxidative stress may explain the observed increased postmenopausal breast cancer risk associated with hormone replacement therapy (HRT). We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
